tiprankstipranks

Barry Flannelly Insider Profile

4 Followers
Barry Flannelly, EVP & General Manager US at Incyte, holds 58.04K shares in Incyte (Ticker: INCY), holds 0.00 shares in Genomic Health (Ticker: GHDX), holds ― shares in Protara Therapeutics (Ticker: TARA).
tipranks
Barry Flannelly

Barry Flannelly
Incyte (INCY)
EVP & General Manager US

Ranked #78,847 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-23.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
0.00%
A breakdown of Barry Flannelly's holdings

Insider Roles

Incyte
(INCY)
EVP & General Manager US
Protara Therapeutics
(TARA)
Director
Roles that Barry Flannelly holds in companies

Most Profitable Insider Trade

Stock:
Incyte
(INCY)
Rating:Informative Sell
Date:Nov 08, 2024 - Today
Return:0.00%
The most profitable trade made by Barry Flannelly

Barry Flannelly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Incyte
Nov 08, 2024
EVP & General Manager US
Uninformative Buy
257.72K
$4.12M
GHDX
Genomic Health
Nov 14, 2019
Uninformative Sell
$0.00
Protara Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Barry Flannelly's performance on stock

Barry Flannelly insider profile FAQ

What is the percentage of profitable transactions made by Barry Flannelly?
The percentage of profitable transactions made by Barry Flannelly is 0%.
    What is the average return per transaction made by Barry Flannelly?
    The average return per transaction made by Barry Flannelly is -23.90%.
      What stocks does Barry Flannelly hold?
      Barry Flannelly holds: INCY, GHDX, TARA stocks.
        What was Barry Flannelly’s latest transaction?
        Barry Flannelly latest transaction was an Uninformative Buy of $257.72K.
          What was Barry Flannelly's most profitable transaction?
          Barry Flannelly’s most profitable transaction was an Informative Sell of INCY stock on November 8, 2024. The return on the trade was 0.00%.
            What is Barry Flannelly's role in Incyte?
            Barry Flannelly's role in Incyte is EVP & General Manager US.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.